Skip to Main Content

Paper Details

Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury.
J Am Soc Nephrol
15
2022
AKI, Acute Kidney Injury, Angiopoietins, Angpt, Angpt-1, Angpt-2, CKD, Heart Failure, Kidney Disease, angiopoietin-1, angiopoietin-2, angiopoietins, heart failure, participants, patients, plasma angiopoietins
Author NameAffiliation
Sherry G MansourClinical Translational Research Accelerator, Yale University School of Medicine
Sherry G MansourYale University School of Medicine
Pavan K BhatrajuUniversity of Washington
Pavan K BhatrajuKidney Research Institute, University of Washington
Francis P WilsonClinical Translational Research Accelerator, Yale University School of Medicine
Francis P WilsonYale University School of Medicine
Ian B StanawayKidney Research Institute, University of Washington
Heather Thiessen-PhilbrookJohns Hopkins University
Alan S GoUniversity of California san francisco
Alan S GoUniversity of California san francisco
Alan S GoStanford University
Alan S GoStanford University
Alan S GoKaiser Permanente Northern California
Talat Alp IkizlerVanderbilt University Medical Center
Edward D SiewVanderbilt University School of Medicine
Amit X GargSchulich School of Medicine and Dentistry, Western University
Amit X GargSchulich School of Medicine and Dentistry, Western University
Amit X Garg
Kathleen D LiuUniversity of California san francisco
Kathleen D LiuUniversity of California san francisco
Jonathan HimmelfarbKidney Research Institute, University of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
Samir M ParikhBeth Israel Deaconess Medical Center, Harvard Medical School
Samir M ParikhBeth Israel Deaconess Medical Center, Harvard Medical School
Chirag R ParikhJohns Hopkins University
  • 1 - 25

Datasets